Becton Dickinson (BDX) was trading at $169.9 as of June 22, 2016. It has a 50-day moving average of $161.3 and a 200-day moving average of $149. As of June 22, 2016, Becton Dickinson’s stock was trading ~32% above its 52-week low of $128.9 on September 28, 2015, and ~1% below its 52-week high of $171.6 on June 9, 2016. The company’s share price has risen ~5.2% since the release of its 2Q16 earnings on May 5, 2016.
Becton Dickinson’s stock price rose by around 3% after the release of its 2Q16 results on May 5, 2016, as the company registered better-than-expected earnings and raised fiscal 2016 guidance. Since May 5, 2016, the company’s stock has traded in the price range of $160.9 and $171.6.
Becton Dickinson has returned ~20% over the last one year. It outperformed the market, represented by the S&P 500 Index, which returned around -1.2% during the same period. The company has registered YTD returns of ~9.3%. It’s trading at a beta of 1.01. Beta indicates the volatility of the stock in comparison to the market. A beta higher than one indicates a stock is more volatile than the market and vice versa. Becton Dickinson’s stock is 1% more volatile than the market.
Peers’ stock performances
As of June 22, 2016, Becton Dickinson’s peers Johnson & Johnson (JNJ), Stryker (SYK), and Medtronic (MDT) had generated returns of 16.6%, 20.4%, and 10%, respectively, over the last 12 months. Investors can consider the PowerShares S&P 500 Low Volatility Portfolio (SPLV), which accounts for ~1% of its total holdings in Becton Dickinson.
In the next article, let’s look at the analysts’ recommendations for Becton Dickinson.